NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT05500508 2024-12-24Oral AMXT 1501 Dicaprate in Combination With IV DFMOAminex Therapeutics, Inc.Phase 1/2 Terminated15 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT04541225 2023-07-14Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNuvation Bio Inc.Phase 1 Terminated74 enrolled
NCT01386580 2015-01-22An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.BBB-Therapeutics B.V.Phase 1/2 Completed84 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00909558 2010-02-24Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerEnvita Medical Center, Inc.Phase 1 Suspended24 enrolled
NCT00338026 2008-07-15A Phase I Study of ECO-4601 in Patients With Advanced CancerThallion PharmaceuticalsPhase 1 Completed26 enrolled